Common cancer mutations of p53 tend either to lower the stability or distort the core domain of the protein or weaken its DNA binding affinity. We have previously analyzed in vitro the effects of mutations on the core domain of p53. Here, we extend those measurements to full-length p53, using either the wild-type protein or a biologically active superstable construct that is more amenable to accurate biophysical measurements to assess the possibilities of rescuing different types of mutations by anticancer drugs. The tetrameric full-length proteins had similar apparent melting temperatures to those of the individual domains, and the structural mutations lowered the melting temperature by similar amounts. The thermodynamic stability of tetrameric p53 is thus dictated by its core domain. We determined that the common contact mutation R273H weakened binding to the gadd45 recognition sequence by ϳ700 -1000 times. Many mutants that have lowered melting temperatures should be good drug targets, although the common R273H mutant binds response elements too weakly for simple rescue.
Common cancer mutations of p53 tend either to lower the stability or distort the core domain of the protein or weaken its DNA binding affinity. We have previously analyzed in vitro the effects of mutations on the core domain of p53. Here, we extend those measurements to full-length p53, using either the wild-type protein or a biologically active superstable construct that is more amenable to accurate biophysical measurements to assess the possibilities of rescuing different types of mutations by anticancer drugs. The tetrameric full-length proteins had similar apparent melting temperatures to those of the individual domains, and the structural mutations lowered the melting temperature by similar amounts. The thermodynamic stability of tetrameric p53 is thus dictated by its core domain. We determined that the common contact mutation R273H weakened binding to the gadd45 recognition sequence by ϳ700 -1000 times. Many mutants that have lowered melting temperatures should be good drug targets, although the common R273H mutant binds response elements too weakly for simple rescue.
The tumor suppressor protein p53 is a transcription factor that plays a critical role in the network of signals that control the fate of a cell (1) . In about half of human tumors, p53 is inactivated as a result of point missense mutations in the sequence-specific DNA binding core domain of the protein (2, 3 (3) (Fig. 1) . From quantitative folding and DNA binding studies of numerous cancer-associated core domain mutants, three phenotypes have been broadly categorized: (i) DNA contact mutations with only minor effects on folding and stability, such as R273H; (ii) mutations that disrupt the local structure, mainly in proximity to the DNA binding surface, which destabilize the protein by Յ2 kcal/ mol relative to wild type, such as G245S; and (iii) highly destabilizing mutations, such as R175H, which destabilize the protein by Ͼ3 kcal/mol (4 -6) . The structural effects of the mutations R249S and R273H have recently been elucidated by x-ray crystallography (7) . p53 has several domains: the N-terminal transactivation domain (residues 1-63) (8) , the proline-rich regulatory domain (residues 64 -92) (9, 10) , the DNA binding core domain (residues 94 -312) (11) , the tetramerization domain (residues 324 -355) (12) , and the C-terminal domain (residues 360 -393) (13) . The core domain and the C-terminal domain bind DNA. The isolated core domain (p53C) 3 binds specifically to a doublestranded DNA consensus site containing two copies of the 10-base pair "half-site" motif 5Ј-PuPuPuC(A/T)(T/A)GPyPyPy-3Ј (Pu ϭ A/G, Py ϭ T/C) that can be separated by up to 13 bases (14) . p53C monomers bind specific DNA to give a 4:1 complex (15, 16) . Binding to a minimal tetrameric p53 construct comprising the core and tetramerization domains is cooperative with a stoichiometry of two dimers per DNA molecule (16) . The C-terminal domain, its post-translational modifications and its role as a regulatory domain have been extensively studied and debated (13, (17) (18) (19) (20) (21) (22) (23) (24) . This domain has been shown to bind nucleic acid in a sequence-nonspecific manner (13, 25) with a strong electrostatic component (26) .
A new approach in cancer therapy is to use drugs that can rescue the activity of mutant p53 (6, (27) (28) (29) . To assess further the feasibility of rescue drug therapy, we have quantitatively analyzed the effect of p53 cancer mutations on the stability of full-length protein and the effect of the contact mutation R273H on p53-DNA interactions. We used an engineered thermostable mutant of p53 core domain (T-p53C), containing the mutations M133L/V203A/N239Y/ N268D (30, 31) to produce p53 mutant proteins suitable for accurate biophysical measurements.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification-T-p53C, T-p53CT, and mutants of these constructs were purified as previously described (16, 31) . The plasmid for human p53 (residues 1-393) subcloned into the polylinker region of vector pET24a(ϩ) (Novagen) using the NdeI and EcoRI restriction sites was kindly provided by C. Blair. Additional point mutations * This work was supported by the Medical Research Council and Cancer
Research UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 3 The abbreviations used are: p53C, p53 core domain (residues 94 -312); T-p53C, thermostable variant of p53 core domain (residues 94 -312) containing the four point mutations M133L, V203A, N239Y, and N268D; T-p53CT, thermostable p53 truncation mutant (residues 94 -360, comprising the core and tetramerization domains); T-p53FL, thermostable variant of p53 full-length protein; DTT, dithiothreitol; K D , dissociation constant; AUC, analytical ultracentrifugation; DSC, differential scanning calorimetry.
were introduced using the QuikChange site-directed mutagenesis kit (Stratagene). The expression vector was transformed into Escherichia coli BL21 for overexpression. Expression cultures were incubated at 37°C at 250 rpm until OD 600 reached ϳ0.8. Zinc sulfate was added to give a final concentration of 100 M, and protein expression was induced with 500 M isopropyl ␤-D-thiogalactoside. Cells were harvested 16 h later by centrifugation. The cell pellet from 3 liters of culture was suspended in cell-cracking buffer of 50 mM NaP i , pH 7.5, 150 mM NaCl, 5 mM DTT, and 15% glycerol and cracked using an Emulsiflex C5 high pressure homogenizer (Glen Creston). The soluble fraction was loaded onto a Heparin HP column and eluted with a 0 -1 M NaCl gradient over 20 column volumes. The pooled fractions from this column were diluted 10-fold with 25 mM Tris/Bis-Tris propane buffer pH 9, 5 mM DTT, and 15% glycerol, loaded onto a Poros 20HQ anionic exchange column and eluted with a 0 -1 M NaCl gradient over 20 column volumes. The pooled fractions were purified further on a Superdex 200 26/60 preparative gel filtration column (Amersham Biosciences) in 25 mM NaP i , pH 7.2, 300 mM NaCl, 5 mM DTT, and 10% glycerol. The purified p53 proteins were greater than 95% pure as judged by SDS/polyacrylamide gel. Protein samples were flash-frozen and stored in liquid nitrogen for further use. DNA Duplex Assembly and Purification-Double-stranded DNAs were assembled from HPLC-purified oligonucleotides and purified according to procedures already described (16, 32) . The oligonucleotides were labeled on the 5Ј-end of the forward strand with fluorescein. Only the forward DNA strand was labeled to avoid energy transfer between fluorophores. The gadd45 promoter sequence was verified against the published recognition element (33) , and encoded by the oligonucleotides 5Ј-fluorescein-GTACAGAACATGTCTAAGCATGCTgGGGAC and 5Ј-GTCCCcAGCATGCTTAG-ACATGTTCTGTAC. Bases in capital letters agree with the published consensus sequence (14) . Nonspecific DNA (random DNA) that did not contain a p53 recognition element was encoded by the oligonucleotides 5Ј-fluorescein-AATATGGTT-TGAAATAAAGAGTAAAGATTTG-3Ј and 5Ј-CAAATCTT-TACTCTTTATTCAAACCATATT-3Ј.
Equilibrium Denaturation-Samples for urea denaturation experiments were prepared using a Hamilton MicrolabM dispenser from stock solutions of urea, buffer, and protein to contain 1 M protein in 25 mM sodium phosphate buffer, pH 7.2, 150 mM KCl, 5 mM DTT, and increasing concentrations of urea. Samples were incubated at 10°C for 14 h prior to measurement. The intrinsic fluorescence spectra of p53, excited at 280 nm, were recorded in the range of 300 -400 nm on a PerkinElmer Life Sciences LS50B spectrofluorometer equipped with a Waters 2700 sample manager and controlled by laboratory software. The data were analyzed as previously described (4) .
Differential Scanning Calorimetry (DSC)-DSC experiments were performed using a Microcal VP-Capillary DSC instrument (Microcal, Amherst, MA) with an active cell volume of ϳ125 l. Temperatures from 10 to 85°C were scanned at a rate of 250°C/h. Protein samples were buffer-exchanged into a buffer of 25 mM sodium phosphate, pH 7.2, 150 mM NaCl, 5 mM DTT. This buffer was also used for baseline scans. For core domain, 100 M protein was used. For full-length protein, 15 M (in monomeric units) protein was used. A pressure of 2.5 bars (nitrogen) was applied to the cell. The data were analyzed with ORIGIN software (Microcal). The average apparent T m value is presented in parentheses in Fig. 2 .
Analytical Centrifugation-All analytical centrifugation (AUC) experiments were performed at 10°C using a Beckman Optima XL-I centrifuge and a 60Ti rotor. To determine DNA binding affinities, samples of 5 M 5Ј-fluorescein-labeled gadd45 DNA and 100 M T-p53 monomers were made up in 25 mM sodium phosphate, pH 7.2, 150 mM KCl, and 5 mM DTT. To measure the stoichiometry and dissociation constant for protein binding to fluorescein-tagged DNA, absorbance values at 495 nm and interference patterns at 675 nm were recorded, and the data were analyzed using UltraSpin software. The apparent dissociation constant per monomer was calculated as Table 2 . This value is equivalent to P 50 .
Fluorescence Anisotropy-Fluorescence anisotropy measurements were recorded on a PerkinElmer Life Sciences LS55 Luminescence Spectrometer equipped with a Hamilton Microlab titrator and controlled by laboratory software. The excitation ( ex ) and emission ( em ) wavelengths used were 480 nm and 530 nm, respectively, and the slit widths for excitation and emission were 15 nm and 20 nm. The photomultiplier voltage FIGURE 1. Wire frame model of p53 core domain bound to gadd45 consensus DNA (PDB ID code 1TSR, molecule B). Secondary structural elements are highlighted by semitransparent ribbons and cylinders. A ␤-sandwich provides the scaffold for the DNA binding surface, which is rich in basic amino acids and contains a zinc ion (yellow sphere). The six residues that are most frequently mutated in human cancer are shown in orange. The small blue spheres indicate the location of the mutation sites in the superstable quadruple mutant T-p53C. Trp 146 (highlighted in green) was used as a fluorescence probe in this study. The figure was generated using MOLSCRIPT (46) and RASTER3D (47) .
used was 950 with an integration time of 5 s for each measurement. The concentrations of tetrameric constructs were 1-50 M (dimers). The initial concentrations of DNA were 4 -10 nM. The experiments were performed at 10°C in 25 mM imidazole, pH 7.2, 213.4 mM NaCl, 5 mM DTT, with a total ionic strength of 225 mM, as described by Weinberg et al. (16) to minimize artifacts caused by nonspecific binding effects. For T-p53CT-R273H, experiments were performed in the presence of 10% glycerol to prevent aggregation. Control experiments comparing T-p53CT binding gadd45 in 0, 5, and 10% glycerol showed minimal differences in binding affinities. Proteins were buffer exchanged into the reaction buffer using NAP-10 columns (Amersham Biosciences), and protein concentrations were measured spectrophotometrically immediately prior to use using molar extinction coefficients calculated according to the method of Gill and von Hippel (48) . p53 was titrated into a cuvette containing fluorescein-labeled DNA, and the solution was stirred for 30 s. After 60 s, the fluorescence and fluorescence polarization values were measured, using an integration time of 5 s. Different data analyses were performed depending on the protein concentrations used.
(i) At concentrations of p53 far below K td : When the affinity for DNA is very high, the measurements are made at concentrations of p53 that are much below the dissociation constant for tetramers into dimers (K td ). It can be assumed that unbound protein is dimeric under the reaction conditions and does not tetramerize until bound to DNA. The binding isotherm simplifies to that of the simple sequential two-site model, which was previously used to describe the sequence-specific DNA binding of p53CT (15, 16) .
(ii) At concentrations of p53 approaching or exceeding K td : At the other extreme, for weak binding to DNA, measurements are made at concentrations of p53 that approach or exceed the value of K td . The concentration of tetramer at each titration point was calculated and plotted to give the K DNA value directly.
RESULTS

Common Cancer Mutations Have a Similar Effect on the Stability of T-p53C, Wild-type p53C, and Full-length p53
We measured the effects of structural hot spot mutations (R175H, G245S, and R282W) and the classic temperaturesensitive mutation V143A on the stability of T-p53C by urea denaturation (Table 1 and Fig. 2A) . Overall, the trends followed the wild-type protein (4, 5) . G245S destabilized the core domain by 1.2 kcal/mol in wild type and 0.8 kcal/mol in T-p53C. The structural mutations V143A, R175H, and R282W that substantially destabilize the wild type by 3.3-3.5 kcal/mol also caused major stability loss in T-p53C, ranging from 2.5-3.7 kcal/mol.
In the full-length protein, the signal from Trp 146 , which was used to monitor the unfolding of the core domain by urea denaturation, is masked by the relatively strong fluorescence signal from 3 tryptophan residues in the natively unfolded N-terminal region. We therefore studied the effects of mutations on the stability of full-length p53 by differential scanning calorimetry (DSC). The observed T m is not the true melting temperature but an apparent one because p53 does not denature reversibly with increasing temperature (5) . Although the data are qualitative, they reflect the relative destabilizing effects of the mutations; the apparent T m values of T-p53C paralleled the reversible urea-induced thermodynamic data (Fig. 2, A and B) . The apparent T m values are also useful for assessing the stability of p53 in vivo. 4 The apparent T m of T-p53C-R273H was virtually the same as T-p53C at 49.9°C. The apparent T m of T-p53C-G245S was reduced to 47.3°C. The apparent T m of T-p53C-R249S was further reduced to 45.0°C. The highly destabilizing mutations, R175H and V143A, greatly reduced the T m to 42.5°C and 43.0°C, respectively. Experiments for full-length p53 were done with ϳ4 M protein. Because the equilibrium constant for fulllength p53 tetramers dissociating into dimers is 300 nM (per p53 dimer at 10°C) (34), the protein should exist as tetramers at this concentration. Control experiments (not shown here) showed no large effects of concentration on aggregation, so the apparent T m values were qualitative but relative as the observed values depend on heating rate.
The apparent T m of wild-type full-length p53 was 45.1°C, close to that of wild-type core domain 44.1°C. In full-length T-p53FL, the cancer mutations G245S, R249S, and R273H showed the same relative effect on stability as in core domain T-p53C (Fig. 2B) . Introduction of the R273H mutation had little effect on the stability, and the apparent T m shifted marginally to 48.2°C. The structural mutation G245S reduced the apparent T m from 49.7°C to 47.3°C. The mutation R249S, which was more destabilizing than the G245S mutation, further reduced the apparent T m to 43.8°C.
Binding of DNA to Full-length p53 and Shorter Constructs
We have previously reported the DNA binding affinities of p53 core domains by analytical ultracentrifugation studies (7) . The affinity of T-p53C-G245S using the same technique under similar conditions was 35 Ϯ 2 M (Table 2) .
We analyzed the binding to tetrameric p53 using two constructs to distinguish between specific DNA binding to the core and nonspecific binding to the C terminus: (i) a minimal tetrameric construct consisting of the core and tetramerization domains (T-p53CT), and (ii) the full-length protein (T-p53FL) (24, 26) . The DNA binding experiments were conducted using fluorescence anisotropy at an ionic strength of 225 mM to reduce nonspecific electrostatic interactions at the DNA binding interface, which is positively charged and contains numerous arginine residues that are involved in DNA binding (16) . Two types of 5Ј-fluorescein-labeled 30-mer double-stranded DNA were tested: one that contained the 20-base pair specific recognition element from the gadd45 promoter (gadd45); another that did not contain a p53 recognition element (random DNA) (16, 32) .
We analyzed the binding data for T-p53CT and T-p53FL using the Hill equation, as previously described (16) (Fig. 3) . The Hill coefficient for binding to gadd45 promoter DNA was 1.95 for T-p53CT and 1.99 for T-p53FL (Fig. 3) , consistent with previous results for p53CT binding p21 and Mdm2 promoter DNA (16) , and indicates a cooperative binding event for T-p53CT and T-p53FL binding gadd45 promoter DNA.
DNA Binding of the Minimal Tetrameric Construct Comprising Core and Tetramerization Domains-Tetrameric
p53 is in a dynamic tetramer-dimer equilibrium (Fig. 4) . The equilibrium constant for the minimal tetrameric construct dissociating into dimers is 400 nM (per p53 dimer at 10°C) (34) . p53 mutants that bind DNA weakly are present as tet- 
TABLE 2
Binding of monomeric p53 to specific gadd45 DNA, as measured by analytical ultracentrifugation at total ionic strength of 210 mM K D values were determined by AUC at 10°C in 25 mM sodium phosphate, pH 7.2, 150 mM KCl, and 5 mM DTT, at a total ionic strength of 210 mM. Measurements were performed with 5 M 5Ј-fluorescein-labeled double-stranded DNA that contained the 20-base pair, specific recognition element from the gadd45 promoter, and 100 M protein. Data were analyzed as described under "Experimental Procedures." Data (except for T-p53C-G245S) have been published (7) .
ramers at the high protein concentrations used. Measurements of the concentration of p53 (in dimers) for 50% saturation (P 50 ) for different constructs and mutants of p53 were made. T-p53CT bound the gadd45 recognition sequence with P 50 of 21 Ϯ 2 nM (Table 3 , Fig. 5A ) and random DNA about 30 times more weakly with P 50 of 680 Ϯ 20 nM (Table  3 and Fig. 5B ). In contrast, the minimal tetrameric T-p53CT-R273H mutant bound gadd45 about 1000 times more weakly than did T-p53CT (see "Discussion"). Nevertheless, it could still discriminate between the two types of DNA used, and bound gadd45 with P 50 of 3000 Ϯ 400 nM, several times more tightly than nonspecific random DNA (P 50 of Ͼ10,000 nM) (Fig. 5, C and D) .
DNA Binding of the Full-length Proteins-
The full-length protein T-p53FL bound gadd45 DNA with P 50 of 4 Ϯ 2 nM, about 5 times more tightly than did T-p53CT (Table 3 and Fig.  6A ). Like T-p53CT, T-p53FL also showed strong selectivity for gadd45 over random DNA, and bound about 90 times more tightly to gadd45 than random DNA (Table 3 and Fig. 6B ). The R273H mutation reduced the binding of gadd45 to the fulllength protein to P 50 of 1400 Ϯ 200 nM (Table 3 and Fig. 6C) . But, this binding is mainly attributable to nonspecific binding to the C terminus (24, 26) , because the dissociation constant for nonspecific DNA was 1500 Ϯ 200 nM (Table 3 and Fig. 6D ). The same is true for T-p53FL-R249S, which is a weakly binding mutant (P 50 of 1200 Ϯ 200 and 850 Ϯ 100 nM, respectively, for binding to specific and nonspecific DNA) (Fig. 7) .
DISCUSSION
Destabilizing Effects of Common Cancer Mutations in p53
Core Domain and Full-length Protein Follow the Same TrendCommon cancer mutations had the same relative effects on the stability of wild-type p53 core domain and the stabilized core domain variant T-p53C. For example, R249S destabilizes both core domain variants by ϳ2 kcal/mol whereas the introduction of the R273H mutation had virtually no effect on stability (7) . The use of this stabilized T-p53 construct enabled us to produce full-length p53 mutants for accurate biophysical measurements. Interestingly, all cancer hot spot mutations tested had the same relative effects on the stability of the full-length protein as measured in isolated core domain (Fig. 8, A and B) . This indicates that the core domain is pivotal in governing the overall stability of p53, and that all mutation-induced stability changes observed at core domain level directly translate into similar relative stability changes in the full-length protein.
Effects of R273H Mutation on Specific DNA Binding of p53-The R273H contact mutation reduced the binding of the gadd45 response element by raising the P 50 for the wild-type minimal tetrameric core and tetramerization domain construct from 21 to 3000 nM ( Table 3) . The contact mutation did not completely abrogate DNA binding, consistent with previous mammalian cell-based studies in which reduced but detectable transactivation function is observed for the mutant R273H (35-37) and mixed tetramers of the R273H mutant with 2 or more wild-type monomers are transcriptionally active (38) . These observations are also in good agreement with crystallographic studies, which show that while a critical DNA contact is lost, the overall architecture of the DNA binding surface is preserved (7). 
TABLE 3
Binding of tetrameric p53 to specific gadd45 DNA and nonspecific random DNA, as measured by fluorescence anisotropy at a total ionic strength of 225 mM Binding affinities are expressed in terms of P 50 values. P 50 is the protein concentration (in dimers) at 50% saturation. The specific and nonspecific DNA used are 5Ј-fluorescein-tagged gadd45 and random DNA, respectively. The oligonucleotide sequences are described under "Experimental Procedures." Comparing Binding to Monomeric, Dimeric, and Tetrameric Constructs-There are various complications in attempting to compare directly the binding of DNA to isolated core domains with oligomeric p53 that is in equilibrium between dimers and tetramers. One problem is that as the dissociation constant of tetrameric p53 into dimers is about 400 nm, the binding of response elements with affinities in the nanomolar region are measured in a p53 concentration range in which it is mainly dimeric. Hence, the Hill constant of close to 2 for the binding of gadd45 DNA to fulllength constructs, showing that the p53 dimers have effectively to associate to tetramers to bind to the response elements that have 4 sites. It may be shown that for tight binding response elements such as gadd45 to wild-type proteins at concentrations Ͻ Ͻ400 nM, the P 50 value is the square root of the product of the dissociation constants of the tetramer into dimer (K td ) and the DNA from the tetramer (K DNA ), i.e. P 50 ϭ ͌K td ⅐K DNA (Fig. 4) . For T-p53CT, substituting the measured value of the dissociation constant for the tetramer to dimer (400 nM) into the equation, together with the P 50 value obtained from DNA binding experiments, gives a value of K DNA for gadd45 and T-p53CT of 1 nM. For weakly binding DNA-protein complexes, such as T-p53CT-R273H, we can obtain the true dissociation constant of DNA from the tetramer, K DNA , by calculating the amount of tetrameric p53 in solution using the 400 nM dissociation constant value and plotting the observed anisotropy against the tetrameric p53 concentration. The K DNA for gadd45 and T-p53CT-R273H was found to be 1000 Ϯ 200 nM. By comparing the K DNA values, it can be seen that the intrinsic binding to the tetramer is weakened by ϳ1000 times on the mutation of R273H.
Protein
The absolute values of binding of DNA to tetrameric constructs cannot be quantitatively compared with the binding to core domains because of differences in molecularity, which lead to vastly different entropies of binding. The effects of mutation can be compared, however. The P 50 values for monomeric core domains binding gadd45 are 10 Ϯ 3 M for T-p53C and 51 Ϯ 4 M for T-p53C-R273H (Table 2) (7). At first sight, it seems that the mutation of R273H in the monomeric core domain weakens binding by only a factor of five. It can be shown that the observed P 50 for four monomers binding to DNA with four binding sites is the fourth root of the product of the four individual dissociation constants for each binding event (ϭ
1/4 ). 5 The true relative binding affinity of "tetrameric" wild-type core domains (i.e. 4 domains to the four-site response element) to the R273H mutant is, therefore, (K 1 K 2 K 3 K 4 ) R273H /(K 1 K 2 K 3 K 4 ) wt , that is (51/10) 4 , ϳ700, and not 5.1, which is within experimental error of that calculated from the tetrameric constructs.
Consequences of Mutations in Vivo-The similarity of the thermodynamic stability of full-length p53 to that of core domain and the parallel effects of destabilizing mutations indicate that the studies on rescuing the stability of core domain provide a valid framework for the design of drugs to rescue destabilized conformations. The rescue of destabilized mutants is a feasible drug strategy. But, our quantitative data on the binding affinity of R273H indicate that it is too weak for functional transactivation of normal p53-responsive genes, as we can see from comparing the apparent K D values for recognition elements that p53 is known to bind weakly (32) with the experimental K D values reported here. For example, wild-type p53CT binds a low affinity promoter sequence PUMA BS1 with P 50 of 260 nM per dimer (32) , about 10 times more tightly than T-p53CT-R273H binding to a high affinity promoter sequence gadd45 with P 50 of 3000 nM. This suggests that the binding of the R273H mutant to low affinity promoter sequences would be even weaker and would be insufficient for functional transactivation. Cell lines containing R273H have been used to test rescue drugs. We suggest that this is an inappropriate mutant as it does not lose stability on mutation but activity by the high loss of affinity. It is difficult to see how its activity could be revived by small molecules.
Mutations in the DNA binding core domain have different, sometimes intermediate, effects on p53 transactivation, cell cycle arrest, and apoptotic functions in various cell types (39, 40) . Possibly, many p53 mutants retain residual binding affinity for DNA, which may not be sufficient for normal function, but still allows them to bind to promoters with high affinity p53 binding sites, as in the p21 promoter, but not to promoters with low affinity sites, as in the Bax promoter (41) . Given the complex nature of interactions and feedback loops in the p53 pathway (42), the differences in binding affinity could result in different levels of cell cycle control and different phenotypes (43, 44) . But, massive up-regulation of a contact mutant could lead to its higher concentration offsetting its weaker binding affinity, especially noticeable for higher affinity response elements.
